US2014348882A1PendingUtilityA1

In vivo delivery of nucleic acids to the liver or liver tissue

Assignee: Veritas Bio LLCPriority: Nov 8, 2006Filed: Aug 1, 2014Published: Nov 27, 2014
Est. expiryNov 8, 2026(~0.3 yrs left)· nominal 20-yr term from priority
A61P 31/12C12N 15/1131C12N 2730/10122C12N 2310/14C12N 2310/53C12N 15/113A61K 31/713A61K 35/34C12N 2310/111C12N 15/111C12N 2320/32C12N 15/85A61P 1/16A61K 35/36Y02A50/30
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention encompasses methods of delivering nucleic acids, including dsRNA, to mammalian target cells in vivo via intercellular transfer, wherein the dsRNA is delivered to or expressed in a first cell different from the target cell, wherein the first cell facilitates delivery of the dsRNA to the target cell.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A method of delivering at least one RNA to a target cell in an animal comprising: transfecting a first cell in vitro with a nucleic acid encoding said RNA, isolating at least one exovesicle from said first cell wherein said exovesicle contains said RNA, and contacting said target cell with said exovesicle. 
     
     
         2 . The method of  claim 1 , wherein said RNA is a dsRNA. 
     
     
         3 . The method of  claim 1 , wherein said first cell is a muscle cell or a skin cell. 
     
     
         4 . The method of  claim 1 , wherein a nucleic acid expressing a transmembrane or surface ligand specific for said target cell is co-transfected with said nucleic acid encoding said RNA. 
     
     
         5 . The method of  claim 4 , wherein said nucleic acid expressing said transmembrane or surface ligand and said nucleic acid encoding said dsRNA are encoded on a single plasmid. 
     
     
         6 . A method of delivering at least one RNA to a target organ or tissue in an animal comprising transfecting at least one first cell ex vivo with a nucleic acid encoding said RNA, and introducing said transfected cell into said animal, wherein said introduction results in said RNA being delivered to at least one second cell in said target organ or tissue, wherein said target organ or tissue is distal from the site of introduction of said transfected first cell. 
     
     
         7 . The method of  claim 6 , wherein said RNA is a dsRNA. 
     
     
         8 . The method of  claim 6 , wherein said first cell is a muscle cell or a skin cell. 
     
     
         9 . The method of  claim 6 , wherein a nucleic acid expressing a transmembrane or surface ligand specific for said target cell is co-transfected with said nucleic acid encoding said RNA. 
     
     
         10 . The method of  claim 9 , wherein said nucleic acid expressing said transmembrane or surface ligand and said nucleic acid encoding said dsRNA are encoded on a single plasmid.

Join the waitlist — get patent alerts

Track US2014348882A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.